Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 6/20 | 0.71 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | ALB | P02768 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.54 |
| ▸ | SIRT5 | Q9NXA8 | 2/20 | 0.52 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.51 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.50 |
| ▸ | THPO | P40225 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | GNPAT | O15228 | 1/20 | 0.49 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1200060 | 1.00 | FOLH1 (0.71) | FOLH1SMN1; SMN2ALBKDM4EMAPK1 | |
| SCHEMBL16393150 | 1.00 | FOLH1 (0.71) | FOLH1SMN1; SMN2ALBKDM4EMAPK1 | |
| Bisorcic SCHEMBL2109666 | 0.94 | FOLH1 (0.64) | FOLH1SMN1; SMN2ALBKDM4EMAPK1 | |
| Bisorcic SCHEMBL2109664 | 0.94 | FOLH1 (0.64) | FOLH1SMN1; SMN2ALBKDM4EMAPK1 | |
| Bisorcic SCHEMBL16238411 | 0.94 | FOLH1 (0.64) | FOLH1SMN1; SMN2ALBKDM4EMAPK1 | |
| SCHEMBL25550095 | 0.93 | FOLH1 (0.64) | FOLH1SMN1; SMN2ALBKDM4EMAPK1 | |
| SCHEMBL14942518 | 0.93 | FOLH1 (0.64) | FOLH1SMN1; SMN2ALBKDM4EMAPK1 | |
| SCHEMBL13901989 | 0.91 | FOLH1 (0.61) | FOLH1SMN1; SMN2ALBKDM4EMAPK1 | |
| SCHEMBL23451113 | 0.89 | FOLH1 (0.63) | FOLH1SMN1; SMN2ALBKDM4EMAPK1 | |
| SCHEMBL17190067 | 0.88 | FOLH1 (0.66) | FOLH1SMN1; SMN2ALBKDM4EMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220002230-A1 | COMPOUND CONTAINING DIPHENYLMETHANE STRUCTURE AND USE THEREOF | GUANGZHOU CONGEN PHARMATEC CO., LTD. (CN) | 2022-01-06 | — | — | US | disclosed |
| US-11014953-B2 | Trigger-activatable metabolic sugar precursors for cancer-selective labeling and targeting | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2021-05-25 | — | — | US | disclosed |
| EP-3712181-A1 | HYALURONIC ACID DERIVATIVE MODIFIED WITH POLY(ETHYLENE GLYCOL) | Chugai Seiyaku Kabushiki Kaisha (JP) | 2020-09-23 | — | — | EP | disclosed |
| WO-2017062800-A1 | TRIGGER-ACTIVATABLE METABOLIC SUGAR PRECURSORS FOR CANCER-SELECTIVE LABELING AND TARGETING | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2017-04-13 | — | — | WO | disclosed |
| US-9558862-B2 | Conductive polymer composition, coated article having antistatic film formed from the composition, and patterning process using the composition | SHIN-ETSU POLYMER CO., LTD. (JP) | 2017-01-31 | — | — | US | disclosed |
| US-9558862-B2 | Conductive polymer composition, coated article having antistatic film formed from the composition, and patterning process using the composition | SHIN-ETSU POLYMER CO., LTD. (JP) | 2017-01-31 | — | — | US | disclosed |
| EP-2868698-B1 | CONDUCTIVE POLYMER COMPOSITION, COATED ARTICLE WHICH IS PROVIDED WITH ANTISTATIC FILM OBTAINED FROM CONDUCTIVE POLYMER COMPOSITION, AND PATTERN FORMING METHOD USING CONDUCTIVE POLYMER COMPOSITION | SHINETSU POLYMER CO (JP) | 2016-12-07 | — | — | EP | disclosed |
| US-9132111-B2 | Topical antimicrobial compositions | LU KEWANG (US) | 2015-09-15 | — | — | US | disclosed |
| US-20150140492-A1 | CONDUCTIVE POLYMER COMPOSITION, COATED ARTICLE HAVING ANTISTATIC FILM FORMED FROM THE COMPOSITION, AND PATTERNING PROCESS USING THE COMPOSITION | SHIN-ETSU POLYMER CO., LTD. (JP) | 2015-05-21 | — | — | US | disclosed |
| US-20150140492-A1 | CONDUCTIVE POLYMER COMPOSITION, COATED ARTICLE HAVING ANTISTATIC FILM FORMED FROM THE COMPOSITION, AND PATTERNING PROCESS USING THE COMPOSITION | SHIN-ETSU POLYMER CO., LTD. (JP) | 2015-05-21 | — | — | US | disclosed |
| US-20090054590-A1 | Multi-armed, monofunctional, and hydrolytically stable derivatives of poly (ethylene glycol) and related polymers for modification of surfaces and molecules | NEKTAR THERAPEUTICS AL, CORPORATION (US) | 2009-02-26 | — | — | US | disclosed |
| EP-0015771-B1 | N-(6-((ACYLAMINOACYLAMINO OR AMINOACYLAMINO)PHENYL)-1,2-DIHYDRO-2-OXONICOTINYL) CEPHALOSPORIN COMPOUNDS, PROCESSES FOR THEIR PRODUCTION, AND COMPOSITIONS CONTAINING THE SAME | WARNER-LAMBERT COMPANY (US) | 1984-06-06 | — | — | EP | disclosed |
| EP-0015773-B1 | N-(6-((ACYLAMINOACYLAMINO OR AMINOACYLAMINO)PHENYL) 1,2-DIHYDRO-2-OXONICOTINYL)PENICILLIN COMPOUNDS, PROCESSES FOR THEIR PRODUCTION AND COMPOSITIONS CONTAINING THEM | WARNER-LAMBERT COMPANY (US) | 1983-07-20 | — | — | EP | disclosed |
| US-4311699-A | Aminoacid derivatives of cephalosporin compounds | HASKELL THEODORE H | 1982-01-19 | — | — | US | disclosed |
| US-4311698-A | Aminoacid derivatives of cephalosporin compounds | HASKELL THEODORE H | 1982-01-19 | — | — | US | disclosed |
| US-4278681-A | N-/6-//ACYLAMINOACYLAMINO OR AMINOACYLAMINO/PHENYL/-1,2-DIHYDRO-2-OXONICOTINYL/PENICILLINS | WARNER-LAMBERT CO. (US) | 1981-07-14 | — | — | US | disclosed |
| US-4267180-A | PENICILLINS AND DERIVATIVES | WARNER-LAMBERT COMPANY (US) | 1981-05-12 | — | — | US | disclosed |
| EP-0015773-A2 | N-(6-((acylaminoacylamino or aminoacylamino)phenyl) 1,2-dihydro-2-oxonicotinyl)penicillin compounds, processes for their production and compositions containing them | WARNER-LAMBERT COMPANY (US) | 1980-09-17 | — | — | EP | disclosed |
| EP-0015771-A1 | N-(6-((acylaminoacylamino or aminoacylamino)phenyl)-1,2-dihydro-2-oxonicotinyl) cephalosporin compounds, processes for their production, and compositions containing the same | WARNER-LAMBERT COMPANY (US) | 1980-09-17 | — | — | EP | disclosed |
| EP-0015772-A1 | N-(2-((acylaminoacylamino or aminoacylamino)phenyl)-4-hydroxy-5-pyrimidinylcarbonyl)cephalosporin compounds, processes for their production, and compositions containing the same | WARNER-LAMBERT COMPANY (US) | 1980-09-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11014953-B2 | Trigger-activatable metabolic sugar precursors for cancer-selective labeling and targeting | GPI, SLC2A1, SLC2A4 | FOLH1 240/4885SMN1; SMN2 3380/4885ALB 1569/4885 |
| US-20220002230-A1 | COMPOUND CONTAINING DIPHENYLMETHANE STRUCTURE AND USE THEREOF | PEPD, VIP, DNPEP | FOLH1 146/4885SMN1; SMN2 2430/4885ALB 632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.